Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2018 Jun;558(7710):E1.
doi: 10.1038/s41586-018-0111-5.

Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren M Lasko  1 , Clarissa G Jakob  1 , Rohinton P Edalji  1 , Wei Qiu  1 , Debra Montgomery  1 , Enrico L Digiammarino  1 , T Matt Hansen  1 , Roberto M Risi  1 , Robin Frey  1 , Vlasios Manaves  1 , Bailin Shaw  1 , Mikkel Algire  1 , Paul Hessler  1 , Lloyd T Lam  1 , Tamar Uziel  1 , Emily Faivre  1 , Debra Ferguson  1 , Fritz G Buchanan  1 , Ruth L Martin  1 , Maricel Torrent  1 , Gary G Chiang  1   2 , Kannan Karukurichi  3 , J William Langston  4 , Brian T Weinert  5 , Chunaram Choudhary  5 , Peter de Vries  6 , Arthur F Kluge  7 , Michael A Patane  8 , John H Van Drie  9 , Ce Wang  10 , David McElligott  11 , Edward A Kesicki  3 , Ronen Marmorstein  12 , Chaohong Sun  1 , Philip A Cole  13 , Saul H Rosenberg  1 , Michael R Michaelides  1 , Albert Lai  1 , Kenneth D Bromberg  14
Affiliations
Published Erratum

Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren M Lasko et al. Nature. 2018 Jun.

Abstract

In the originally published version of this Letter, the authors Arthur F. Kluge, Michael A. Patane and Ce Wang were inadvertently omitted from the author list. Their affiliations are: I-to-D, Inc., PO Box 6177, Lincoln, Massachusetts 01773, USA (A.F.K.); Mitobridge, Inc. 1030 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA (M.A.P.); and China Novartis Institutes for BioMedical Research, No. 4218 Jinke Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai 201203, China (C.W.). These authors contributed to the interpretation of results and design of compounds. In addition, author 'Edward A. Kesicki' was misspelled as 'Ed Kesicki'. These errors have been corrected online.

PubMed Disclaimer

Erratum for

  • Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
    Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, Hansen TM, Risi RM, Frey R, Manaves V, Shaw B, Algire M, Hessler P, Lam LT, Uziel T, Faivre E, Ferguson D, Buchanan FG, Martin RL, Torrent M, Chiang GG, Karukurichi K, Langston JW, Weinert BT, Choudhary C, de Vries P, Van Drie JH, McElligott D, Kesicki E, Marmorstein R, Sun C, Cole PA, Rosenberg SH, Michaelides MR, Lai A, Bromberg KD. Lasko LM, et al. Nature. 2017 Oct 5;550(7674):128-132. doi: 10.1038/nature24028. Epub 2017 Sep 27. Nature. 2017. PMID: 28953875 Free PMC article.

Publication types

LinkOut - more resources